Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O'Laughlin

Showing results (301-310 of 325) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysisMarta Díaz-Menéndez, Concetta Castilletti, Kevin O'Laughlin, et al.
Frontiers in Public Health|February 14, 2024
Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infectionKelli N O'Laughlin, Robin E Klabbers, Imtiaz Ebna Mannan, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Plos Genetics|February 6, 2014
Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS lociSusan K Service, Tanya M Teslovich, Christian Fuchsberger, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Emerging Infectious Diseases|July 21, 2021
Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 TestingSarah E Smith-Jeffcoat, Mitsuki Koh, Adam Hoffman, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 33

Showing results (301-310 of 325) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Leukemia|October 4, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment responseMeagan A Jacoby, Eric D Duncavage, Ajay Khanna, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysisMarta Díaz-Menéndez, Concetta Castilletti, Kevin O'Laughlin, et al.
Frontiers in Public Health|February 14, 2024
Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infectionKelli N O'Laughlin, Robin E Klabbers, Imtiaz Ebna Mannan, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Plos Genetics|February 6, 2014
Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS lociSusan K Service, Tanya M Teslovich, Christian Fuchsberger, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Emerging Infectious Diseases|July 21, 2021
Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 TestingSarah E Smith-Jeffcoat, Mitsuki Koh, Adam Hoffman, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 33